See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Who wouldn't love to find a drug to help prevent or at least delay the ...

Second-quarter financial results from U.S. pharmaceutical companies gave an early glimpse into life after Zocor, the blockbuster cholesterol drug from Merck that lost patent protection with just a ...

Despite price cutting measures taken by Merck to keep Zocor competitive, generic versions of Zocor (simvastatin) that became available during the last week of June have already captured 49% of new ...

Whitehouse Station, NJ - Merck's blockbuster cholesterol-lowering agent, Zocor (simvastatin), loses its US patent protection tomorrow, when the first generic competitors will appear. This move is ...

Both Lipitor (atorvastatin) and Zocor (simvastatin) are in a class of drugs called statins, which reduce blood levels of LDL, the lousy type of cholesterol. All the statins work slightly differently, ...

JERUSALEM, June 23 (UPI) -- Teva said Friday it as been approved to market the first generic version of Merck's anti-cholesterol drug Zocor. The news comes the same day Merck's patent on its ...

With its blockbuster cholesterol-fighting drug Zocor about to face generic competition Friday, Merck & Co. is taking steps to aggressively price the drug. A spokesman at UnitedHealth Group Inc., one ...

When the FDA announced that the popular cholesterol drug simvastatin, brand name Zocor, would need a new label warning, it simply reinforced something that many doctors already knew: The highest ...